Thomas S - Search Results

1

Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma.

Troy JD, Weissfeld JL, Youk AO, Thomas S, Wang L, Grandis JR. Troy JD, et al. Among authors: thomas s. Head Neck Pathol. 2013 Dec;7(4):344-55. doi: 10.1007/s12105-013-0447-y. Epub 2013 May 4. Head Neck Pathol. 2013. PMID: 23645351 Free PMC article.

2

The current state of head and neck cancer gene therapy.

Thomas SM, Grandis JR. Thomas SM, et al. Hum Gene Ther. 2009 Dec;20(12):1565-75. doi: 10.1089/hum.2009.163. Hum Gene Ther. 2009. PMID: 19747066 Free PMC article. Review.

3

Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer.

Argiris A, Lee SC, Feinstein T, Thomas S, Branstetter BF 4th, Seethala R, Wang L, Gooding W, Grandis JR, Ferris RL. Argiris A, et al. Among authors: thomas s. Oral Oncol. 2011 Oct;47(10):961-6. doi: 10.1016/j.oraloncology.2011.07.034. Epub 2011 Sep 1. Oral Oncol. 2011. PMID: 21889392 Free PMC article. Clinical Trial.

4

PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells.

Sun Q, Ming L, Thomas SM, Wang Y, Chen ZG, Ferris RL, Grandis JR, Zhang L, Yu J. Sun Q, et al. Among authors: thomas sm. Oncogene. 2009 Jun 18;28(24):2348-57. doi: 10.1038/onc.2009.108. Epub 2009 May 4. Oncogene. 2009. PMID: 19421143 Free PMC article.

5

Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation.

Wheeler SE, Suzuki S, Thomas SM, Sen M, Leeman-Neill RJ, Chiosea SI, Kuan CT, Bigner DD, Gooding WE, Lai SY, Grandis JR. Wheeler SE, et al. Among authors: thomas sm. Oncogene. 2010 Sep 16;29(37):5135-45. doi: 10.1038/onc.2009.279. Epub 2010 Jul 12. Oncogene. 2010. PMID: 20622897 Free PMC article.

6

Collagen type XI α1 facilitates head and neck squamous cell cancer growth and invasion.

Sok JC, Lee JA, Dasari S, Joyce S, Contrucci SC, Egloff AM, Trevelline BK, Joshi R, Kumari N, Grandis JR, Thomas SM. Sok JC, et al. Among authors: thomas sm. Br J Cancer. 2013 Dec 10;109(12):3049-56. doi: 10.1038/bjc.2013.624. Epub 2013 Nov 14. Br J Cancer. 2013. PMID: 24231953 Free PMC article.

7

Nucleic acid targeting: towards personalized therapy for head and neck cancer.

Parsel SM, Grandis JR, Thomas SM. Parsel SM, et al. Among authors: thomas sm. Oncogene. 2016 Jun 23;35(25):3217-26. doi: 10.1038/onc.2015.424. Epub 2015 Nov 23. Oncogene. 2016. PMID: 26592450 Free PMC article. Review.

8

Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor.

Lui VW, Thomas SM, Zhang Q, Wentzel AL, Siegfried JM, Li JY, Grandis JR. Lui VW, et al. Oncogene. 2003 Sep 18;22(40):6183-93. doi: 10.1038/sj.onc.1206720. Oncogene. 2003. PMID: 13679857

9

Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma.

Thomas SM, Coppelli FM, Wells A, Gooding WE, Song J, Kassis J, Drenning SD, Grandis JR. Thomas SM, et al. Cancer Res. 2003 Sep 1;63(17):5629-35. Cancer Res. 2003. PMID: 14500405

10

Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation.

Thomas SM, Grandis JR. Thomas SM, et al. Cancer Treat Rev. 2004 May;30(3):255-68. doi: 10.1016/j.ctrv.2003.10.003. Cancer Treat Rev. 2004. PMID: 15059649 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,203 results

Search Page

Filters